Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Nature Reviews. Clinical Oncology|February 13, 2021
PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.Cancer Medicine|September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer PatientsDouglas Tremblay, Carina Seah, Thomas Schneider, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2024
Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable PopulationsSheena Bhalla, Vijaya Natchimuthu, Jessica L Lee, et al.Lung Cancer (Amsterdam, Netherlands)|July 9, 2023
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancerSheena Bhalla, Farjana J Fattah, Chul Ahn, et al.International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief ReportYuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, et al.Translational Lung Cancer Research|December 10, 2025
Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancerMary E Gwin, Mitchell S von Itzstein, Jialiang Liu, et al.Population Health Management|May 23, 2023
Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation InterventionSimon J Craddock Lee, Jessica Lee, Hong Zhu, et al.Cancer Reports (Hoboken, N.J.)|May 25, 2021
Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancersSheena Bhalla, Huili Zhu, Jung-Yi Lin, et al.Thrombosis Research|August 28, 2020
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net PopulationSheena Bhalla, Heidi A Hamann, Tanushree Prasad, et al.Pageof 3